Immutep (IMMP) Operating Leases (2019 - 2026)
Immutep's (IMMP) quarterly Operating Leases came in at $205818.2 in Q2 2026, up 56.47% on a YoY basis from $131538.6 in Q2 2025, and up 20.56% quarter-over-quarter from $170712.3 in Q4 2025.
Analysis
Immutep (IMMP) Operating Leases (2019 - 2026) Analysis & Trends
Immutep (IMMP) has reported Operating Leases for 8 consecutive years, with $205818.2 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases rose 56.47% year-over-year to $205818.2; the trailing twelve-month figure through Jun 2026 stood at $205818.2 (up 56.47% YoY), and the FY2026 full-year result was $205818.2, up 56.47% from the prior year.
- Operating Leases climbed to $205818.2 in Q2 2026 per IMMP's latest filing, from $170712.3 in the prior quarter.
- Across five years, Operating Leases topped out at $262546.7 in Q2 2023 and bottomed at $89851.7 in Q4 2022.
- Historically, Operating Leases has averaged $169242.0 across 5 years, with a median of $170712.3 in 2025.
- The sharpest annual moves came in 2022 and 2026: Operating Leases slumped 42.09% in 2022, then surged 56.47% in 2026.
- Over 5 years, Operating Leases stood at $89851.7 in 2022, then soared by 52.23% to $136785.5 in 2023, then increased by 24.86% to $170787.3 in 2024, then fell by 0.04% to $170712.3 in 2025, then rose by 20.56% to $205818.2 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $205818.2, $170712.3, and $131538.6 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Immutep | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205,818.15 |
| Dec 31, 2025 | 170,712.27 |
| Jun 30, 2025 | 131,538.58 |
| Dec 31, 2024 | 170,787.31 |
| Jun 30, 2024 | 153,960.64 |
| Dec 31, 2023 | 136,785.47 |
| Jun 30, 2023 | 262,546.69 |
| Dec 31, 2022 | 89,851.67 |
| Jun 30, 2022 | 201,177.57 |
| Dec 31, 2021 | 155,145.89 |
| Jun 30, 2021 | 222,012.29 |
| Dec 31, 2020 | 155,221.31 |
| Jun 30, 2020 | 171,971.23 |
| Dec 31, 2019 | 86,114.59 |
| Jun 30, 2019 | 235,421.73 |